Startups
Sinopia Biosciences, Inc. is a privately held biotechnology company advancing novel therapeutics using its proprietary LEADS® (LEarn And DiScover) drug discovery platform. Sinopia’s LEADS® platform integrates high-throughput omics data, AI/machine learning, and network analyses. Sinopia is advancing multiple first-in-class programs with high unmet need, including its lead program for Parkinson’s disease. Sinopia is headquartered at JLABS in San Diego, California.
Overview
Location
United States
Total raised
$2.5M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 12, 2024 | Sinopia Secures Phase II SBIR Grant | Sinopia, a San Diego, CA-based biotechnology company advancing novel therapeutics identified using its proprietary computational drug discovery platform, has been awarded a Phase II SBIR grant totaling $2.2M from the National Institute of D... |
| Jun 3, 2024 | Sinopia Biosciences Receives SBIR Grant | Sinopia Biosciences, a San Diego, CA-based biotechnology company advancing novel therapeutics identified using its proprietary computational drug discovery platform, received a Small Business Innovation Research (SBIR) grant from the Nation... |
Reviews 0
FAQ about Sinopia Biosciences
How much funding has Sinopia Biosciences raised?
Sinopia Biosciences has raised $2.5M in total across 1 funding round.
What has the press written about Sinopia Biosciences?
Parsers VC has collected 3 articles mentioning Sinopia Biosciences, among them “Sinopia Secures Phase II SBIR Grant” (Sep 12, 2024) and “Sinopia Biosciences Receives SBIR Grant” (Jun 3, 2024).
Is Sinopia Biosciences still active?
Yes, Sinopia Biosciences is active; its latest activity on Parsers VC dates from Oct 21, 2026.